LSX
Advertising Networks · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
52 Upper St, London, Greater London, N1 ...Phone Number
+44 2036375908Website
www.lsxleaders.comRevenue
$7.2 MillionIndustry
About LSX
Is LSX your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when LSX launches new products
Click to see if LSX had a recent Job posting/layoffs
LSX, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if LSX is spiking on competitors!
Check if LSX has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at LSX
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on LSX recently announced quarterly report
Funding: Get notified immidiatlly once LSX has new funding data
Recommended Actions
Find VP level buyers at LSX
Find 2 more new buyers
Compare Similar Companies to LSX
Compare insights from companies similar to LSX, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
LSX
Company Profile Activity
Activity Insights
LSX is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
LSX is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about LSX.
LSX Tech Stack
A closer look at the technologies used by LSX
LSX News & Media
ISA Pharmaceuticals to Present at Business Conferences in May 2022
OEGSTGEEST, The Netherlands, April 27, 2022 /PRNewswire/ -- ISA Pharmaceuticals B.V., a clinical stage biotech company developing immunotherapies to treat cancers and infectious diseases, is pleased to announce that its representatives will be participating and presenting at the following...invIOs to present at upcoming conferences
VIENNA, Austria, Feb. 03, 2022 (GLOBE NEWSWIRE) -- invIOs GmbH, a privately held biotechnology company developing novel therapies for cancer, today announced the participation at three upcoming investor conferences, the BIO CEO & Investor Conference, Sachs 15th Annual European Life Sciences CEO Forum and LSX World Congress. invIOs management will hold company presentations at these events and participate in one panel discussion. Further, the company will attend BIO-Europe Spring and Bio€quity EuCompany presentation at LSX Nordic Congress 2021
From September 7-17 Isofol participated in LSX Nordic Congress, an opportunity for 1:1 meetings with Nordic life science executives focused on International Strategy, Investment, Partnering and Deal Making. See Isofol´s CEO, Jarl Ulf Jungnelius’ company presentation from the event below. LSX Nordic Congress 2021 - presentation >> (https://youtu.be/Xw3n60_O5ck) [image] (https://youtu.be/Xw3n60_O5ck)Lipum participate at the LSX Nordic Congress
News: Umeå, 25 august, 2021. Lipums CEO Einar Pontén will present Lipum at LSX Nordic Virtual Congress (https://www.lsxleaders.com/lsx-nordic-congress) 6-17 September. The LSX Nordic Congress is annual investment and partnering conference for the Nordic life science and healthcare industry. [image] For further information, please contact: Einar Pontén, CEO E-post: einar.ponten@lipum.se Mobil: +46 70 578 34 95 Web: www.lipum.se About Lipum Lipum AB (publ) is a biopharmaceutical company specialize
Top Advertising Networks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding LSX
LSX is an influential community of senior life science decision makers. The company connects senior life science executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses. The company achieve this through a programme of high-level conferences and networking events, via content that showcases an... Read More